MediBeacon Inc.

Biotechnology company · Saint Louis, Missouri, United States

MediBeacon Inc. is a biotechnology company headquartered in Saint Louis, Missouri, United States. Its earliest recorded incorporation is in 2012. The US FDA lists 1 medical device site registered to the company. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $181,504 in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $16 million sold in a notice filed in 2025.

medibeacon.comProfile compiled from public records. Is this your company? Request a correction or update

MediBeacon at a glance

Typebiotechnology company
HeadquartersSaint Louis, Missouri, United States
Earliest incorporation on record2012
FDA-registered sites1
Employees (per SBIR records)5
SEC CIK1601807

What does MediBeacon do?

Device types listed with the FDA

Transdermal test for assessment of glomerular filtration rate

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $181,504 in total (2016). NIH funding came from the National Eye Institute.

Private fundraising reported to the SEC

10 Form D notices; the most recent reported $16.1 million sold (2025).

Where is MediBeacon located?

Headquarters: Saint Louis, Missouri, United States

  • Creve Coeur, MissouriMedibeacon Inc. · FDA device site

Frequently asked questions about MediBeacon

Where is MediBeacon headquartered?

MediBeacon Inc. is headquartered in Saint Louis, Missouri, United States.

What does MediBeacon do?

MediBeacon Inc. is a biotechnology company.

When was MediBeacon founded?

The earliest incorporation on record for MediBeacon Inc. is in 2012, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.